Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 17 hours 41 min ago
Notice of NIAMS' Participation in RFA-TR-22-030, "Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed)"
Notice NOT-AR-23-012 from the NIH Guide for Grants and Contracts
Notice of Special Interest (NOSI): Administrative Supplement for NIDCD National Human Ear Resource Network Coordination Center
Notice NOT-DC-23-002 from the NIH Guide for Grants and Contracts
Request for Information (RFI) on Update to NOT-OD-05-034 Guidance on Prompt Reporting of Noncompliances to OLAW
Notice NOT-OD-23-063 from the NIH Guide for Grants and Contracts
Notice of Correction to RFA-AR-24-001, "NIAMS Skin Biology and Diseases Resource-based Centers (P30 - Clinical Trial Not Allowed)"
Notice NOT-AR-23-013 from the NIH Guide for Grants and Contracts
Notice of Pre-Application and Technical Assistance Webinar for RFA-MH-23-115 and RFA-MH-23-116 "Bidirectional Influences Between Adolescent Social Media Use and Mental Health (R01 and R21 Clinical Trial Optional)"
Notice NOT-MH-23-180 from the NIH Guide for Grants and Contracts
Time-Sensitive Research Opportunities in Environmental Health Sciences (R21 Clinical Trial Not Allowed)
Funding Opportunity RFA-ES-23-004 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) is intended to support novel environmental health research in which an unpredictable event or policy change provides a limited window of opportunity to collect human biological samples or environmental exposure data. The primary motivation of the FOA is to understand the consequences of natural and human-made disasters, emerging environmental public health threats, and policy changes in the U.S. and abroad. A distinguishing feature of an appropriate study is the need for rapid review and funding, substantially shorter than the typical NIH grant review/award cycle, for the research question to be addressed and swiftly implemented.
Start Planning Your 2023 NIH Grants Conference Experience - Free, Virtual Event on February 1 and 2 - Register Today!
Notice NOT-OD-23-064 from the NIH Guide for Grants and Contracts
Notice of Change to RFA-PM-23-002, Small Grants to Enhance the Use of the All of Us Research Programs Data (R03 Clinical Trial Not Allowed)
Notice NOT-PM-23-007 from the NIH Guide for Grants and Contracts
Notice of Correction to NOT-ES-23-001"Need to Expire and Reissue RFA-ES-22-001 Maintaining and Enriching Environmental Epidemiology Cohorts to Support Scientific and Workforce Diversity (U24 Clinical Trial Not Allowed) to Clarify Review Criteria
Notice NOT-ES-23-004 from the NIH Guide for Grants and Contracts
Notice of Special Interest (NOSI): Computational and Statistical Methods to Enhance Discovery from Health Data
Notice NOT-LM-23-001 from the NIH Guide for Grants and Contracts
Notice of Special Interest (NOSI): Research on the Etiology, Early Detection, Screening and Prevention of Early-Onset Colorectal Cancer
Notice NOT-CA-23-018 from the NIH Guide for Grants and Contracts
Notice of Special Interest (NOSI): Understanding Sudden Death in the Young Through Research
Notice NOT-HL-22-040 from the NIH Guide for Grants and Contracts
Notice of Special Interest (NOSI): Technology Development for Cancer Control and Population Science Research
Notice NOT-CA-23-037 from the NIH Guide for Grants and Contracts
Notice of Special Interest (NOSI): Career Development Opportunities for Research Within the Mission of the Division of Cancer Prevention at the National Cancer Institute
Notice NOT-CA-23-035 from the NIH Guide for Grants and Contracts
Notice of Extension of NOT-HL-21-030 "Notice of Special Interest (NOSI): Heart, Lung, Blood and Sleep Focused Ancillary Studies to Large Ongoing Clinical Studies (Revised)"
Notice NOT-HL-23-071 from the NIH Guide for Grants and Contracts
Notice of Technical Assistance Webinar for NOT-EB-22-001 - Notice of Special Interest (NOSI): Small Business Initiatives for Innovative Diagnostic Technology for Improving Outcomes for Maternal Health
Notice NOT-EB-23-001 from the NIH Guide for Grants and Contracts
Notice of Correction to the Non-responsive Application Criteria in PAR-22-173: Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)
Notice NOT-CA-23-040 from the NIH Guide for Grants and Contracts
Notice of Correction to the Non-responsive Application Criteria in PAR-22-174: Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional)
Notice NOT-CA-23-039 from the NIH Guide for Grants and Contracts
Notice of Special Interest (NOSI): Priority Research Opportunities in Crisis Response Services
Notice NOT-MH-23-140 from the NIH Guide for Grants and Contracts
Ruth L. Kirschstein National Research Service Award (NRSA) Short-Term Institutional Research Training Grant (Parent T35)
Funding Opportunity PA-23-080 from the NIH Guide for Grants and Contracts. The National Institutes of Health (NIH) will award Ruth L. Kirschstein National Research Service Award (NRSA) Short-Term Institutional Research Training Grants (T35) to eligible, domestic institutions to develop and/or enhance research training opportunities for predoctoral students interested in careers in biomedical, behavioral, or clinical research. Many NIH Institutes and Centers (ICs) use this NRSA program exclusively to support intensive, short-term research training experiences for health professional students (medical students, veterinary students, and/or students in other health-professional programs) during the summer. This program is also intended to encourage training of graduate students in the physical or quantitative sciences to pursue research careers by short-term exposure to, and involvement in, the health-related sciences. The training should be of sufficient depth to enable the trainees, upon completion of the program, to have a thorough exposure to the principles underlying the conduct of biomedical research. This Funding Opportunity Announcement (FOA) does not allow appointed Trainees to lead an independent clinical trial, but does allow them to obtain research experience in a clinical trial led by a mentor or co-mentor.